Humira: The Most Financially Successful Drug Ever!
Humira: The Most Financially Successful Drug Ever! Humira has made $200 Billion over the course of its pharmaceutical life. The original Humira patent expired, but the makers of Humira--AbbVie--filed an additional 132 patents and extended its patent-life to 2023. During that time, AbbVie raised the price of Humira 30 times from $522 per syringe to $2,984 per syringe. It now costs $78,000 per year to treat one patient with Humira. Consequently, AbbVie rose to be worth $270 Billion and is the 23rd most valuable company on the stock market... $80 Billion larger than the Walt Disney Company. Express Scripts, Optum and Prime Therapeutics will offer biologic alternatives to Humira in 2023, but CVS Caremark has yet to announce any alternative to the expensive medication. Humira shows how completely ineffective PBMs are in controlling specialty pharmacy costs. Alternative solutions include: 1) Travel to Mexico/Canada to buy specialty drugs for less, 2) Hire own specialists (e.g. rheumatologists) who will be better stewards of the employers resources while still following clinical best-practices, 3) Have lawyers try to get plan members that take specialty medications on Disability so that Medicare will cover their medication costs, 4) Legislative Advocacy to counter the Pharma lobbying that allowed for confiscatory pricing of specialty pharmacy medications. Sources: https://www.fiercepharma.com/special-... https://news.bloomberglaw.com/ip-law/... https://www.fiercehealthcare.com/paye... https://www.prnewswire.com/news-relea... https://www.bloomberg.com/news/articl... https://www.biopharmadive.com/news/hu... https://clincalc.com/DrugStats/Drugs/... https://endpts.com/house-committee-un... https://www.liberatedstocktrader.com/... https://www.fiercepharma.com/pharma/h... https://nces.ed.gov/fastfacts/display... AHealthcareZ is 200+ Healthcare Finance Educational Videos. 💥 BOOK: Check out Dr. Bricker’s Book 16 Lessons in the Business of Healing here: https://www.ahealthcarez.com/healthca... AHealthcareZ Viewers Include: Employee Benefits Professionals, HR, CFOs, Insurance Brokers, Benefits Consultants, Doctors and Nurses in Leadership Roles, Hospital and Health System Administrators, Health Insurance Carrier and PBM Professionals, Pharma and Med Device Professionals, Academic Professors and Students in Healthcare Administration and Public Health. 90,000+ Views Per Month Across All Platforms. Visit AHealthcareZ.com to Subscribe to the Healthcare Finance Video Newsletter.

Pharmacy Benefit Managers (PBMs) Explained - Learn How the Money Flows

Blockbuster drug Humira has new competition. Here’s why that matters

Future Healthcare Profits To Be $513B Per Year

Dr. Grant Stevens and AbbVie CEO Discuss $63 BILLION Allergan Acquisition

Largest Selling Drug in America is... Keytruda. What's Keytruda?

How Prescription Drug Coverage Works: Formulary Tiers, PBM, Rebates, Spread-Pricing Explained

Humira 5 days after first jab. An HONEST review

Why Employers Change Insurance Brokers and Benefits Consultants

Silicon Valley's new miracle drug

Dr. Thomas Mather a.k.a The TickGuy Shares Tick Prevention Tips | The Daily Show

10 GLP 1 Mistakes That Are Ruining Your Weight Loss

HUMIRA- what I think and my experience

Specialty Pharmacy Scam - Same Drug Ranges from $37.41 to $2,172

Prescription Medication Prior Authorization Explained

Utilization Management Explained

Electronic Medical Records Are a Mess! Here's Why.

Biosimilar Medications What You NEED to Know in 2025!

Inflation Reduction Act: The Real Healthcare Agenda

Plan Sponsors Are Paying Millions for MSK Injuries That Would Have Healed Themselves — Here's Why

